Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Regular use of NSAIDs decreases risk of breast cancer
February 23rd, 2006
A recent study highlights the potential of nonsteroidal anti-inflammatory drugs (NSAIDs) for the prevention of breast cancer. A case-control study published January 30, 2006, in the open-access journal BMC Cancer (www.biomedcentral.com) observed that daily use of selective COX-2 inhibitors, including celecoxib (Celebrex) and rofecoxib (Vioxx), was associated with a 71% reduction in the risk of breast cancer. Non-selective COX-2 inhibitors, such as aspirin and ibuprofen, also reduced the risk of breast cancer. Randall Harris and colleagues at Ohio State University College of Medicine and Public Health collected data on 323 patients with...
Source: Women's Health Weekly (2006-02-23)
|
